<DOC>
	<DOCNO>NCT00747071</DOCNO>
	<brief_summary>This clinical study design evaluate safety efficacy oral administration food additive colostrum derive antibody Clostridium difficile prevention Clostridium difficile associate disease ( CDAD ) .</brief_summary>
	<brief_title>Safety Validation Efficacy Oral Administration Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Age 18 old Written inform consent At least 3 unformed watery stool 2 previous 24 hour period . Confirmed diagnosis C. difficile associate diarrhea Pregnant breast feed woman Known allergy milk milk product Other etiology diarrhea Active Chronic condition : IBD , short bowel syndrome , ischemic colitis Ileus Pseudomembranous colitis White blood count &gt; 50,000 Blood stool Laxatives motility drug within 12 hour Inability participate adequate follow Clinically unstable Investigator deem unsuitable Immune suppression ( disease treatment ) GI surgery Past intestinal parasite</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Clostridium difficile</keyword>
	<keyword>diarrhea</keyword>
	<keyword>colostrum</keyword>
</DOC>